학술논문

Long-term utilization and benefit of luspatercept in transfusion-dependent, erythropoiesis-stimulating agent-refractory or -intolerant patients with lower-risk myelodysplastic syndromes with ring sideroblasts
Document Type
Article
Source
In: Leukemia. (Leukemia, November 2023, 37(11):2314-2318)
Subject
Language
English
ISSN
14765551
08876924